NPI: 1457313223 · EASTON, PA 18045 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/05/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/05/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,014 | $25K |
| 2019 | 8,912 | $53K |
| 2020 | 826 | $45K |
| 2021 | 2,203 | $160K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 7,401 | 649 | $250K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 5,884 | 350 | $19K |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,594 | 319 | $9K |
| J1756 | Injection, iron sucrose, 1 mg | 442 | 135 | $3K |
| 83970 | 523 | 420 | $808.44 | |
| 82108 | 34 | 32 | $573.78 | |
| 85041 | 363 | 332 | $558.96 | |
| 85048 | 318 | 305 | $558.50 | |
| A4657 | Syringe, with or without needle, each | 615 | 589 | $530.40 |
| 82728 | 229 | 221 | $99.55 | |
| 83550 | 239 | 231 | $63.15 | |
| 83540 | 239 | 231 | $45.48 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 32 | 28 | $27.14 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 42 | 40 | $9.56 |